Acquirer | Target | Price |
---|---|---|
Horizon Pharma plc | Raptor Pharmaceuticals Corp. | $800 million |
Allergan plc | Vitae Pharmaceuticals Inc. | $639 million |
Aspen Pharmacare Holdings | Rights to GSK anesthesia portfolio | $202.4 million |
Atos SE | Anthelio Helathcare Solutions Inc. | $200 million |
Joint venture | Town Village portfolio | $180 million |